Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
D003622:Dapsone / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000473:pathology; D009132:Muscles / Q000473:pathology; D009166:Mycobacterium leprae / Q000187:drug effects*; D009420:Nervous System / Q000473:pathology; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use
D003622:Dapsone; D012293:Rifampin